Jean‐Philippe Surivet

1.4k total citations
27 papers, 1.1k citations indexed

About

Jean‐Philippe Surivet is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Jean‐Philippe Surivet has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 10 papers in Molecular Biology and 10 papers in Biochemistry. Recurrent topics in Jean‐Philippe Surivet's work include Traditional and Medicinal Uses of Annonaceae (10 papers), Asymmetric Synthesis and Catalysis (8 papers) and Cocoa and Sweet Potato Agronomy (5 papers). Jean‐Philippe Surivet is often cited by papers focused on Traditional and Medicinal Uses of Annonaceae (10 papers), Asymmetric Synthesis and Catalysis (8 papers) and Cocoa and Sweet Potato Agronomy (5 papers). Jean‐Philippe Surivet collaborates with scholars based in United States, France and Switzerland. Jean‐Philippe Surivet's co-authors include Barry M. Trost, Hong C. Shen, Jean‐Michel Vatèle, Li Dong, Catherine Sylvain, F. Dean Toste, J. GORÉ, Jean‐Noël Volle, Peter Seiler and Christopher Kohl and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Jean‐Philippe Surivet

24 papers receiving 1.0k citations

Peers

Jean‐Philippe Surivet
Jean‐Philippe Surivet
Citations per year, relative to Jean‐Philippe Surivet Jean‐Philippe Surivet (= 1×) peers Hari Babu Mereyala

Countries citing papers authored by Jean‐Philippe Surivet

Since Specialization
Citations

This map shows the geographic impact of Jean‐Philippe Surivet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Philippe Surivet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Philippe Surivet more than expected).

Fields of papers citing papers by Jean‐Philippe Surivet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Philippe Surivet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Philippe Surivet. The network helps show where Jean‐Philippe Surivet may publish in the future.

Co-authorship network of co-authors of Jean‐Philippe Surivet

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Philippe Surivet. A scholar is included among the top collaborators of Jean‐Philippe Surivet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Philippe Surivet. Jean‐Philippe Surivet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Surivet, Jean‐Philippe, Melanie Keßler, Christopher Kohl, et al.. (2025). Discovery of IDOR-1117-1680, a dual orexin receptor antagonist with fast onset and short duration of action for the treatment of insomnia. Bioorganic & Medicinal Chemistry. 122. 118132–118132.
2.
Surivet, Jean‐Philippe, Melanie Keßler, Catherine Vaillant, et al.. (2024). Discovery, synthesis and SAR of 2-acyl-1-biarylmethyl pyrazolidines, dual orexin receptor antagonists designed as fast and short-acting sleeping drugs. Bioorganic & Medicinal Chemistry. 112. 117892–117892. 3 indexed citations
3.
Panchaud, Philippe, Jean‐Philippe Surivet, Stefan Diethelm, et al.. (2019). Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration. Journal of Medicinal Chemistry. 63(1). 88–102. 14 indexed citations
4.
Surivet, Jean‐Philippe, Thierry Bruyère, Daniel Bur, et al.. (2017). Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria. Journal of Medicinal Chemistry. 60(9). 3776–3794. 26 indexed citations
5.
Lepak, Alexander J., Peter Seiler, Jean‐Philippe Surivet, et al.. (2016). In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 60(6). 3626–3632. 7 indexed citations
6.
Trost, Barry M., Hong C. Shen, & Jean‐Philippe Surivet. (2004). Biomimetic Enantioselective Total Synthesis of (−)-Siccanin via the Pd-Catalyzed Asymmetric Allylic Alkylation (AAA) and Sequential Radical Cyclizations. Journal of the American Chemical Society. 126(39). 12565–12579. 95 indexed citations
7.
Trost, Barry M., Jean‐Philippe Surivet, & F. Dean Toste. (2004). Ruthenium-Catalyzed Enyne Cycloisomerizations. Effect of Allylic Silyl Ether on Regioselectivity. Journal of the American Chemical Society. 126(47). 15592–15602. 66 indexed citations
8.
Trost, Barry M., Hong C. Shen, Li Dong, Jean‐Philippe Surivet, & Catherine Sylvain. (2004). Synthesis of Chiral Chromans by the Pd-Catalyzed Asymmetric Allylic Alkylation (AAA):  Scope, Mechanism, and Applications. Journal of the American Chemical Society. 126(38). 11966–11983. 152 indexed citations
9.
Trost, Barry M., Hong C. Shen, & Jean‐Philippe Surivet. (2003). An Enantioselective Biomimetic Total Synthesis of (−)‐Siccanin. Angewandte Chemie International Edition. 42(33). 3943–3947. 78 indexed citations
10.
Trost, Barry M., Hong C. Shen, Li Dong, & Jean‐Philippe Surivet. (2003). Unusual Effects in the Pd-Catalyzed Asymmetric Allylic Alkylations:  Synthesis of Chiral Chromans. Journal of the American Chemical Society. 125(31). 9276–9277. 110 indexed citations
11.
Trost, Barry M., Hong C. Shen, Li Dong, & Jean‐Philippe Surivet. (2003). Unusual Effects in the Pd‐Catalyzed Asymmetric Allylic Alkylations: Synthesis of Chiral Chromans.. ChemInform. 34(46). 1 indexed citations
12.
Trost, Barry M., Hong C. Shen, & Jean‐Philippe Surivet. (2003). An Enantioselective Biomimetic Total Synthesis of (−)‐Siccanin. Angewandte Chemie. 115(33). 4073–4077. 24 indexed citations
13.
Trost, Barry M. & Jean‐Philippe Surivet. (2001). An Atom-Economic Three-Carbon Chain Extension to Give Enamides. Angewandte Chemie International Edition. 40(8). 1468–1471. 20 indexed citations
14.
Trost, Barry M. & Jean‐Philippe Surivet. (2001). An Atom-Economic Three-Carbon Chain Extension to Give Enamides. Angewandte Chemie. 113(8). 1516–1519. 5 indexed citations
15.
Surivet, Jean‐Philippe & Jean‐Michel Vatèle. (1999). Total synthesis of antitumor Goniothalamus styryllactones. Tetrahedron. 55(45). 13011–13028. 77 indexed citations
16.
Surivet, Jean‐Philippe & Jean‐Michel Vatèle. (1998). First total synthesis of (−)-8-epi-9-deoxygoniopypyrone. Tetrahedron Letters. 39(52). 9681–9682. 25 indexed citations
17.
Surivet, Jean‐Philippe & Jean‐Michel Vatèle. (1998). A short and efficient total synthesis of the cytotoxic (+)-goniodiol and (+)-9-deoxygoniopypyrone. Tetrahedron Letters. 39(40). 7299–7300. 19 indexed citations
18.
Surivet, Jean‐Philippe, J. GORÉ, & Jean‐Michel Vatèle. (1996). Total synthesis of (+)-goniodiol. Tetrahedron Letters. 37(3). 371–374. 29 indexed citations
19.
Surivet, Jean‐Philippe, J. GORÉ, & Jean‐Michel Vatèle. (1996). Enantioselective synthesis of (+)-goniodiol and of its naturally occurring acetylated analogs. Tetrahedron. 52(47). 14877–14890. 28 indexed citations
20.
Surivet, Jean‐Philippe, Jean‐Noël Volle, & Jean‐Michel Vatèle. (1996). Easy access to an enantiopure precursor of (+)-goniodiol. Tetrahedron Asymmetry. 7(11). 3305–3308. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026